Targeted Therapy in Noida

Personalized Targeted Cancer Treatment in Noida

Targeted therapy is a type of cancer treatment that uses medicines designed to act on specific biological or molecular characteristics involved in the growth and survival of cancer cells.

Unlike treatments that affect many rapidly dividing cells, targeted medicines are designed to act on particular targets associated with cancer. These targets may include specific proteins, receptors, genes or molecular pathways.

Dr. Jyoti Gupta Anand, Medical Oncologist in Noida and Greater Noida, follows a personalized approach to cancer treatment. When clinically appropriate, she considers pathology, molecular characteristics, biomarkers, cancer stage, previous treatment and the patient's overall health when determining whether targeted therapy may have a role in treatment.

Targeted therapy is not suitable for every cancer or every patient. Its usefulness depends on whether the cancer has an identifiable and clinically relevant target for which an appropriate treatment is available.

What Is Targeted Therapy?

Targeted therapy is an important component of modern medical oncology and precision cancer treatment.

Cancer develops when abnormal cells acquire changes that allow them to grow, divide or survive in ways that differ from normal cells. Some cancers contain specific molecular changes that can be targeted with medicines.

Targeted therapy aims to interfere with these specific mechanisms.

Depending on the medicine and cancer, targeted treatments may:

• Block signals that encourage cancer cell growth
• Interfere with specific proteins
• Block blood vessel formation that supports tumor growth
• Target abnormal receptors
• Act on specific genetic or molecular alterations
• Help prevent cancer cells from growing or spreading

The exact mechanism depends on the targeted medicine and the cancer being treated.

How Does Targeted Therapy Work?

Cancer cells can contain changes in genes, proteins or signaling pathways that help them grow and survive.

A targeted medicine may be designed to interfere with one of these characteristics.

For example, a cancer may contain a particular receptor or molecular alteration that contributes to cancer growth. If an appropriate medicine exists for that target, targeted therapy may be considered as part of the treatment plan.

This is why molecular testing and biomarker evaluation can be important in selected cancers.

However, finding a genetic or molecular alteration does not automatically mean that targeted therapy will be appropriate. The result must be interpreted in the context of the cancer type, stage, previous treatment and available treatment options.

Targeted Therapy and Precision Oncology

Targeted therapy is closely connected with Precision Oncology.

Precision oncology aims to use relevant information about an individual patient's cancer to help guide treatment decisions.

This information can include:

• Pathology
• Cancer subtype
• Cancer stage
• Biomarkers
• Genetic alterations
• Molecular characteristics
• Previous treatment
• Overall health

The objective is to identify treatment approaches that are relevant to the individual cancer rather than assuming that every patient with the same broad cancer diagnosis should receive identical treatment.

Dr. Jyoti Gupta Anand incorporates this personalized approach into cancer treatment planning when molecular or biomarker information is clinically relevant.

Biomarker Testing for Targeted Therapy

Biomarker testing may help identify characteristics of cancer cells that could influence treatment decisions.

Depending on the type of cancer, testing may look for specific proteins, receptors, gene changes or other molecular characteristics.

The type of testing required varies between cancers.

For example, some cancers may require testing for a specific receptor, while others may require broader molecular profiling.

The appropriate test is determined based on the patient's diagnosis and the treatment decisions being considered.

What Is Molecular Testing?

Molecular testing examines genetic or molecular characteristics associated with cancer.

Depending on the test, it may identify:

• Gene mutations
• Gene fusions
• Gene amplifications
• Specific receptors
• Protein expression
• Other molecular alterations

Molecular information can sometimes help identify whether a patient may be eligible for a particular targeted treatment.

Testing may be performed on tumor tissue, blood or another appropriate specimen depending on the clinical situation and the test being considered.

Why Is Biomarker Testing Important?

Not every targeted medicine works for every cancer.

A targeted treatment generally works when the cancer contains the relevant biological characteristic that the medicine is designed to act upon.

Therefore, testing may help answer questions such as:

• Does the cancer have a particular molecular alteration?
• Is there an actionable target?
• Is an approved or clinically appropriate treatment available for that target?
• Could another treatment be more appropriate?
• Is additional molecular testing required?

Treatment decisions should always consider the complete clinical picture rather than relying on a single laboratory result.

Targeted Therapy for Different Types of Cancer

Targeted therapy has applications across several cancer types. Its role varies according to the specific cancer, stage and molecular characteristics.

Targeted Therapy for Breast Cancer

Some breast cancers contain specific receptors or molecular characteristics that can be targeted with medicines.

For selected patients, targeted treatment may be considered based on factors such as:

• Breast cancer subtype
• Hormone receptor status
• HER2 status
• Cancer stage
• Previous treatment
• Other relevant clinical factors

Targeted treatment may be used alone or alongside chemotherapy, hormonal therapy or other systemic treatments depending on the treatment plan.

Targeted Therapy for Lung Cancer

Molecular testing has an important role in the treatment planning of selected lung cancers.

Some lung cancers contain specific molecular alterations for which targeted medicines may be available.

Depending on the diagnosis, testing may be considered for relevant molecular alterations and biomarkers.

If an actionable alteration is identified and an appropriate therapy is available, targeted treatment may form part of the patient's medical oncology plan.

Targeted Therapy for Colorectal Cancer

Targeted therapy can be relevant to selected patients with colorectal cancer.

Treatment decisions may depend on:

• Tumor location
• Cancer stage
• Molecular characteristics
• Biomarkers
• Previous treatment
• Overall health

Molecular testing can help identify characteristics that may influence systemic treatment selection.

Targeted Therapy for Kidney Cancer

Targeted medicines have an established role in selected kidney cancers.

Depending on the disease and treatment setting, targeted treatments may act on pathways involved in tumor growth and blood vessel development.

The appropriate treatment is selected based on the cancer's characteristics and the patient's individual clinical condition.

Targeted Therapy for Ovarian Cancer

Selected ovarian cancers may have molecular or genetic characteristics that can influence treatment planning.

Depending on the diagnosis, genetic or molecular evaluation may be considered when determining appropriate systemic treatment options.

Targeted or maintenance treatment may be appropriate in selected clinical situations.

Targeted Therapy for Other Cancers

Targeted therapies are also being used and studied across a growing range of cancer types.

Their role may depend on whether a particular tumor contains a clinically relevant molecular alteration for which an appropriate treatment is available.

This is one reason modern oncology increasingly incorporates pathology, molecular testing and biomarker information into treatment planning.

Targeted Therapy Before or After Surgery

Targeted therapy may be incorporated into a cancer treatment plan before or after surgery in selected situations.

The timing depends on the type and stage of cancer, available evidence and the overall treatment strategy.

For some cancers, systemic treatment may be used before surgery.

For others, treatment may be considered after surgery based on disease characteristics and the risk of recurrence.

The appropriate sequence is determined by the oncology team.

Targeted Therapy for Advanced and Metastatic Cancer

Targeted therapy can be particularly relevant in selected advanced or metastatic cancers when an actionable molecular alteration is identified.

In these situations, treatment may aim to:

• Control cancer growth
• Slow disease progression
• Reduce disease burden
• Maintain quality of life
• Manage advanced cancer

The expected benefit varies according to the cancer and the specific molecular target.

Targeted therapy does not guarantee a response, and treatment response needs to be monitored over time.

Can Targeted Therapy Be Combined With Chemotherapy?

Yes, in selected cancer treatment protocols, targeted therapy may be combined with chemotherapy.

The combination depends on the type of cancer, molecular characteristics, stage and established treatment approaches.

In other situations, targeted therapy may be used without chemotherapy or combined with another systemic treatment.

The choice should be individualized by the treating oncology team.

Explore Chemotherapy in Noida

How Long Does Targeted Therapy Continue?

There is no single treatment duration for targeted therapy.

The duration can depend on:

• Cancer type
• Stage
• Target being treated
• Treatment response
• Side effects
• Previous treatment
• Overall treatment goals

Some patients may continue treatment for an extended period when the cancer remains controlled and treatment is tolerated.

The treating oncologist determines the appropriate treatment duration and follow-up plan.

How Is Response to Targeted Therapy Evaluated?

The oncology team may use different methods to assess treatment response.

Depending on the cancer, this may include:

• Clinical examination
• Blood tests
• Tumor markers when relevant
• CT scans
• MRI
• PET-CT
• Other imaging
• Disease-specific investigations

The appropriate assessment depends on the cancer and treatment.

Treatment may be continued, modified or changed depending on response, progression and tolerability.

What Happens During a Targeted Therapy Consultation?

During a Targeted Therapy Consultation in Noida, Dr. Jyoti Gupta Anand reviews the patient's diagnosis and available medical information.

The consultation may involve:

Reviewing the Cancer Diagnosis

The exact cancer type and subtype are important when considering targeted treatment.

Reviewing Pathology

Pathology reports help establish the nature and characteristics of the tumor.

Reviewing Molecular Reports

If molecular or biomarker testing has already been performed, the results can be evaluated for potentially relevant treatment targets.

Reviewing Previous Treatment

Previous surgery, chemotherapy, radiation, immunotherapy or targeted treatment can influence future treatment options.

Evaluating Overall Health

Other medical conditions and current medicines may affect treatment selection.

Discussing Treatment Options

The potential role of targeted therapy and other available treatment approaches can then be discussed based on the individual clinical situation.

Why Choose Dr. Jyoti Gupta Anand for Targeted Therapy?

Dr. Jyoti Gupta Anand is a Medical Oncologist in Noida and Greater Noida with a personalized approach to cancer treatment.

Her approach to targeted therapy includes:

Personalized Treatment Planning

Treatment recommendations are based on the patient's individual cancer characteristics rather than cancer type alone.

Molecular and Biomarker Consideration

When clinically relevant, molecular and biomarker information can be incorporated into treatment planning.

Evidence-Based Oncology

Treatment decisions are made using relevant clinical evidence alongside the patient's individual circumstances.

Comprehensive Cancer Care

Targeted therapy is considered as part of the broader cancer treatment strategy, which may also involve chemotherapy, immunotherapy, surgery, radiation therapy or hormonal treatment.

Clear Patient Communication

Patients and families are provided understandable information about the diagnosis, treatment options and potential benefits and risks.

Frequently Asked Questions

Book a Targeted Therapy Consultation in Noida

If you or a family member has been diagnosed with cancer and targeted therapy has been recommended or is being considered, a medical oncology consultation can help you understand whether this treatment may be relevant to your diagnosis.

Dr. Jyoti Gupta Anand provides personalized targeted therapy and precision oncology guidance in Noida and Greater Noida.